Glucose-induced microvascular functional changes in nondiabetic rats are stereospecific and are prevented by an aldose reductase inhibitor.
about
Diabetic complications within the context of aging: Nicotinamide adenine dinucleotide redox, insulin C-peptide, sirtuin 1-liver kinase B1-adenosine monophosphate-activated protein kinase positive feedback and forkhead box O3Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells.Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels.New trends in the etiopathogenesis of diabetic peripheral neuropathy.The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery.Effect of diabetes and elevated glucose on nitric oxide-mediated neurotransmission in rat anococcygeus muscle.Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestat.Clinical and angiographic features associated with coronary collateralization in stable angina patients with chronic total occlusion.Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.Effects of glucose, insulin or aldose reductase inhibition on responses to endothelin-1 of aortic rings from streptozotocin-induced diabetic rats.Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability.
P2860
Q26749486-3A9B4418-9C6E-4B71-A21D-EC79138D6F60Q34170105-AF04A0FF-05DE-4D31-9B37-EB38A0B9279CQ34174519-A122614F-6D90-4EFD-8488-4C87E146BE85Q34288458-2F305116-8EB0-463C-B8CB-C919971DB5EDQ34793415-F515772D-7314-4E76-ABDB-75E4A00E275FQ35872123-77F0F91A-F260-4E1C-B4C1-2EB1E040F594Q35874337-8395DA38-1DB1-4D07-BE61-4F18B60778EFQ37076603-0D5B361F-DC59-4546-A2FE-3DBD5DE19625Q37366616-454B2FD6-E98D-46C2-B509-37974F72D516Q39681036-E0A6A10D-F44A-440E-A825-FB239CE02EA6Q42717393-D02573D3-2A99-4B23-B026-084279DB7348Q46141799-134BE049-DC5B-45A7-844F-FBD35E6B9CEC
P2860
Glucose-induced microvascular functional changes in nondiabetic rats are stereospecific and are prevented by an aldose reductase inhibitor.
description
1990 nî lūn-bûn
@nan
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Glucose-induced microvascular ...... an aldose reductase inhibitor.
@ast
Glucose-induced microvascular ...... an aldose reductase inhibitor.
@en
Glucose-induced microvascular ...... an aldose reductase inhibitor.
@nl
type
label
Glucose-induced microvascular ...... an aldose reductase inhibitor.
@ast
Glucose-induced microvascular ...... an aldose reductase inhibitor.
@en
Glucose-induced microvascular ...... an aldose reductase inhibitor.
@nl
prefLabel
Glucose-induced microvascular ...... an aldose reductase inhibitor.
@ast
Glucose-induced microvascular ...... an aldose reductase inhibitor.
@en
Glucose-induced microvascular ...... an aldose reductase inhibitor.
@nl
P2093
P2860
P356
P1476
Glucose-induced microvascular ...... an aldose reductase inhibitor.
@en
P2093
J R Williamson
W R Sherman
P2860
P304
P356
10.1172/JCI114549
P407
P577
1990-04-01T00:00:00Z